ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $209,644 | +63428.5% | 10,307 | -32.1% | 0.00% | -40.0% |
| Q1 2023 | $330 | -99.8% | 15,184 | +147.3% | 0.01% | +25.0% |
| Q4 2021 | $213,000 | -24.7% | 6,140 | -43.7% | 0.00% | -20.0% |
| Q2 2021 | $283,000 | +54.6% | 10,902 | -3.3% | 0.01% | -37.5% |
| Q4 2019 | $183,000 | -47.6% | 11,275 | +13.2% | 0.01% | -33.3% |
| Q3 2019 | $349,000 | – | 9,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |